###begin article-title 0
Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects
###end article-title 0
###begin p 1
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest</bold>
Conflict of interest: The authors have declared that no conflict of interest exists.
###end p 1
###begin p 2
###xml 434 442 <span type="species:ncbi:9606">patients</span>
###xml 444 447 <span type="species:ncbi:9606">Gp3</span>
###xml 533 541 <span type="species:ncbi:9606">patients</span>
###xml 670 678 <span type="species:ncbi:9606">patients</span>
###xml 810 817 <span type="species:ncbi:9606">patient</span>
###xml 979 987 <span type="species:ncbi:9606">patients</span>
###xml 1386 1394 <span type="species:ncbi:9606">patients</span>
This study aimed to evaluate the plasma homocysteine (tHcy) and folate levels as well as the methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Egyptian subjects. Fasting total homocysteine (tHcy) and the (MTHFR) C677T mutation were evaluated in 50 healthy young control males (age 35-50 years, Gp1), 50 elderly males age ranged between 50-75 years without any cardiovascular diseases (Gp2) and 50 age matched elderly male patients (Gp3) with myocardial infarction. There was a significant elevation of plasma tHcy in the patients group and Gp2 compared to the young control group (Gp1). The total plasma homocysteine (tHcy) in the control group, Gp2 and the patients group were 17.99 +/- 9.76, 39.9 +/- 20.06 and 43.8 +/- 13.13 mumol/L respectively. The frequency of the TT genotype was 12% in the patient group compared with 8 % in the young healthy controls and elderly subjects (Gp2). The CT genotype constituted 36%, 48% and 44% in the control group, Gp2 and the patients group respectively. There was no significant difference in the occurrence of the TT genotype between the studied groups. Plasma tHcy correlated positively with age, total cholesterol, urea, creatinine, glucose levels and carotid intimal thickness (CIT). Conclusion: The MTHFR mutation does not seem to be associated with either high tHcy or the occurrence of cardiovascular diseases in the studied patients. However, elevated plasma tHcy level positively correlates with age in the studied subjects.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 567 568 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
Homocysteine lies at an important metabolic branch point of methionine metabolism, between the remethylation and transsulfuration pathways 1. These lead to the formation of methionine and cystathionine, respectively 2,3. Several enzymes regulate these pathways under normal conditions 4 -6. Methionine formation is tightly tied to a vitamin B12-dependent enzyme 4 ,7,8 methionine synthase, which uses 5-methyltetrahydrofolate as a carbon donor 6 . This donor is synthesized by the methylenetetrahydrofolate reductase (MTHFR) gene from 5,10-methylene-tetrahydrofolate 9,10. Reduction in the activity of these enzymes caused by congenital defects and/or deficiencies in folate may affect the normal homocysteine pathway 9, 11.
###end p 4
###begin p 5
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 829 837 <span type="species:ncbi:9606">patients</span>
A relationship between hyperhomocystinemia and cardiovascular disease is well established 12 -15. A thermolabile variant of MTHFR, with reduced specific activity has been described 16. Frosst et al 17 identified that a substitution of cytosine (C) by thymine (T) at nucleotide 677 of the MTHFR gene that converts an alanine to a valine residue was responsible for the thermolability of MTHFR. Actually, the frequency of the mutated allele was quite high, depending on the ethnic group analyzed 18 -21. Some authors suggested that the homozygosity for the MTHFR C677T polymorphism was associated with an increased risk of coronary heart disease 9,22 whereas others failed to demonstrate this association 23-25. Furthermore, a recent meta-analysis study pointed at a moderate increase in plasma homocysteine and the risk of CVD in patients with MTHFR mutation 26.
###end p 5
###begin p 6
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
The tHcy level is strongly dependent on the folate and vitamin B12 status of each individual 27 ,11,28. Plasma tHcy may be increased in cases of severe, folate deficiency 8 and folate supplements reduce plasma tHcy levels 29. The response to folate supplements is affected by the number of the 677T alleles in the MTHFR gene, with the strongest response in 677T homozygotes 30. On the other hand, the association between carotid and coronary artery disease is well recognized 31 and ultrasonography of the carotid arteries with measurement of the carotid intimal thickness (CIT) had been shown to correlate with the severity of atherosclerosis 31. Some studies showed a strong correlation between elevated plasma homocysteine, MTHFR mutation and CIT 32,33 while others gave equivocal results 34,35.
###end p 6
###begin p 7
###xml 231 239 <span type="species:ncbi:9606">patients</span>
No data are available about the frequency of the MTHFR mutation and its relation to tHcy in the Egyptian population. Thus the aim of the present study was to determine tHcy level and its relationship to MTHFR C677T polymorphism in patients with established coronary heart disease, age and sex matched elderly subjects and in healthy young controls.
###end p 7
###begin title 8
2. Material and methods
###end title 8
###begin title 9
Subjects
###end title 9
###begin p 10
###xml 790 791 790 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 805 808 805 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12)</sub>
###xml 861 868 861 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">primary</italic>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
###xml 310 313 <span type="species:ncbi:9606">Gp3</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
###xml 447 455 <span type="species:ncbi:9606">patients</span>
The current study was carried on three groups. A control group (n=50) consisted of healthy young male volunteers, their age ranged between 35-50 years (Gp1). Another group of healthy elderly subjects not complaining of any cardiovascular disease their age ranged between 50-75 years (Gp2). The patients group (Gp3) consisted of a total of 50 unrelated male patients with past history of myocardial infarction (age ranged between 50-75 years). All patients and controls were living in the same geographic area of Northern Egypt (Alexandria), all of them had the same life style (non of them was heavy smoker, had excessive alcohol consumption or special dietary habit). The exclusion criteria for all groups were as follows: vitamins supplementation (e.g. betaine, choline, folate, vitamin B6, or vitamin B12), the presence of any form of cancer, liver disease, primary renal disease or any collagenic diseases.
###end p 10
###begin p 11
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 59 67 <span type="species:ncbi:9606">Patients</span>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
All subjects gave informed consent before the study began. Patients who had history of myocardial infarction (confirmed by ECG findings and elevated troponin T) were included in the study. All patients and controls had a full clinical examination, including history taking, blood pressure measurement and carotid ultrasonography for measurement of the carotid artery intimal thickness to assess the degree of atherosclerosis 36. This was done using the ultrasonic machine TOSHIBA core-vision equipped with high frequency linear array transducer. The examination was done for the right and left common carotid arteries and the mean values of the two sites were used in the analysis. The transducer was positioned over the common carotid artery screening it from the origin up to the carotid bifurcation looking for any changes, plaque formation with measurement of the vessel thickness. Measurement of the CIT was done at the far wall of the vessel 1cm proximal to its bifurcation. Mean CIT was calculated as the average of five measurements to each common carotid artery 36.
###end p 11
###begin title 12
Blood Collection
###end title 12
###begin p 13
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
All blood samples were collected after an overnight fast (>10 hours) by venipuncture into an EDTA containing tube. A separated aliquot was kept for DNA extraction. Plasma samples were obtained by double centrifugation at room temperature for 15 minutes at 2000g. The plasma aliquots were immediately frozen at -70degreesC until use.
###end p 13
###begin title 14
Laboratory measurements
###end title 14
###begin p 15
Biochemical investigations including blood glucose, cholesterol, triglycerides, high density lipoprotein, urea and creatinine were carried out using Kone Lab. auto-analyzer. Plasma tHcy was determined by immunoassay (Abbott Laboratories, North Chicago, IL, U.S.A.). Plasma folate levels were measured by radioimmunoassay using a commercial kit (Dualcount Charcoal Boil Assay, Diagnostic Products Corporation, Los Angeles, CA).
###end p 15
###begin title 16
MTHFR mutation analysis
###end title 16
###begin title 17
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNA Extraction:</italic>
DNA Extraction:
###end title 17
###begin p 18
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
Genomic DNA was isolated from nucleated blood cells using a phenol chloroform method 37. DNA samples were kept at -80masculineC till analysed.
###end p 18
###begin title 19
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCR-RFLP analysis</italic>
PCR-RFLP analysis
###end title 19
###begin p 20
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinf</italic>
###xml 171 177 171 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR,</italic>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 337 338 333 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The C677T MTHFR gene mutation was detected by PCR-RFLP analysis using Hinf I restriction analysis of a 198-bp polymerase chain reaction-amplified fragment in the gene for MTHFR, according to Frosst et al 17. Briefly, about 50 to 80 ng DNA samples were amplified in a final volume of 25 microL containing 1xPCR buffer with 1.5 mmol/L MgCl2, 2 unit Taq DNA polymerase, 100 micromol/L dNTP, and 0.5 micromol/L of each primer (5'-TGAAGGAGAAGGTGTCTGCGGGA-3' and 5'-AGGACGGTGCGGTGAGAGTG-3'). PCR was performed in a GeneAmp, thermocycler (Biorad, USA), and the profile consisted of an initial melting step of 2 min at 94degreesC; followed by 35 cycles of 30 s at 94degreesC, 30 s at 61degreesC, and 30 s at 72degreesC; and a final elongation step of 7 min at 72degreesC.
###end p 20
###begin p 21
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinf</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinf</italic>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">677C</italic>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">677T</italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinf</italic>
The restriction enzyme Hinf I (Promega, UK) was used to distinguish the C677T polymorphism, and the gain of a Hinf I restriction site occurs in the polymorphic allele. The wild genotype (677C) has a single band representing the entire 198-bp fragment, and the heterozygous genotype (677T) results in three fragments of 198, 175 and 23 bp, while the homozygous for the MTHFR mutation results in 2 fragments 175 and 23 bp. Finally the products of the Hinf I digestion were electrophoresed on 3% agarose gel.
###end p 21
###begin p 22
###xml 162 169 <span type="species:ncbi:9606">persons</span>
To ensure quality control, genotyping was performed with blinding to case/control status, and random samples of cases and controls were tested twice by different persons, and the results were concordant for all masked cases.
###end p 22
###begin title 23
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Statistical analysis:</italic>
Statistical analysis:
###end title 23
###begin p 24
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 431 432 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 601 602 599 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 601 602 599 600 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>P</italic></bold>
The distributions of plasma tHcy concentrations were positively skewed; therefore, they were transformed logarithmically to approximate normal distribution, and such data were analysed statistically. Statistical analysis of the data analysis was carried out using the ANOVA test. Prevalence of alleles and genotype among cases and control subjects were counted and compared with Hardy-Weinberg predictions 38. Chi-square test (chi 2, Fisher's exact test) was used to test the distribution of the different genotypes in the different groups. For correlation studies, Pearson correlation test was used. P value of < 0.05 was considered statistically significant. Statistical analysis was performed using SPSS 10 statistical Package.
###end p 24
###begin title 25
3. Results
###end title 25
###begin p 26
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TI">I</xref>
###xml 293 300 <span type="species:ncbi:9606">patient</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 449 452 <span type="species:ncbi:9606">Gp3</span>
###xml 679 687 <span type="species:ncbi:9606">patients</span>
###xml 695 698 <span type="species:ncbi:9606">Gp3</span>
###xml 798 805 <span type="species:ncbi:9606">patient</span>
The results of some clinical data and biochemical results of the different groups included in this study are shown in table I. Results are expressed as the (range) mean +/- SD. As expected there was a significant increase in the blood pressure level with age which was especially noted in the patient group (age ranged between 50 and 75 years). The mean values of the carotid intimal thickness (CIT) were significantly higher in the patients group (Gp3) and the elderly healthy control group (Gp2) compared with the healthy young control group (Gp1). As regard the glycemic state, there was a significant increase in the blood glucose level both fasting and post-prandial in the patients group (Gp3) compared with Gp1 and Gp2. Also total cholesterol and creatinine were significantly higher in the patient group compared with the control and Gp2 (P< 0.05).
###end p 26
###begin p 27
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Plasma folate showed no significant difference between the patients group and the other two groups. There was poor correlation between the plasma tHcy and folate level.
###end p 27
###begin p 28
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="TII">II</xref>
###xml 799 807 <span type="species:ncbi:9606">patients</span>
Figure 1 shows an agarose gel illustrating the different genotypes of the C667T mutation. The wild type CC shows a single band at the 198 base pair (Bp). The heterozygote CT showed two bands, one at the 198 and the other at the 175 base pair respectively (the third band of 23 base pairs could not be visualized on the agarose gel). The homozygote TT showed a single band at the 175 Bp. Table II shows the frequency of each genotype in the three studied groups and the results of the Chi square testing comparing each genotype in the three different groups. There was no significant difference in the occurrence of the TT genotype in any of the studied groups (P>0.05). Also the prevalence of the different genotypes did not deviate from the Hardy-Weinberg equilibrium for the control group, Gp2 or patients group.
###end p 28
###begin p 29
###xml 287 288 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 197 204 <span type="species:ncbi:9606">patient</span>
###xml 212 215 <span type="species:ncbi:9606">Gp3</span>
As regard the plasma tHcy, the means +/- SD of Gp1, GP2 and GP3 were 17.99 +/- 9.76, 39.9 +/- 20.06 and 43.8 +/- 13.13 mumol/L respectively. There was a significant elevation of plasma tHcy in the patient group (Gp3) and healthy elderly (Gp2) compared to the control group (Gp1) (Figure 2).
###end p 29
###begin p 30
###xml 676 677 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 451 459 <span type="species:ncbi:9606">patients</span>
Plasma tHcy levels were compared in the CC and TT genotypes in the different groups to investigate the effect of the mutant allele (T). There was no significant difference regarding the tHcy between the CC and TT genotypes in Gp1 or Gp2. The CC genotype had a plasma tHcy of 18.74 +/- 11.26 and 38.55 +/- 22.63 mumol/L, while the TT genotype had a plasma tHcy of 12.2 +/- 4.58 and 36.25 +/- 8.96 in Gp1 and Gp2 respectively. On the other hand, in the patients group the CC genotype had an even significantly higher plasma tHcy when compared with the TT genotype (P<0.05). The CC and the TT genotypes had plasma tHcy of 51.09 +/- 28.37 and 22.33 +/- 6.71 respectively. (Figure 3)
###end p 30
###begin p 31
When plasma tHcy was correlated with age, there was a significant positive correlation. The correlation coefficient value was 0.564. There was also a significant positive correlation between the level of the tHcy and the total cholesterol, urea, creatinine and the fasting and postprandial blood glucose. The correlation was significant at the 0.01 level.
###end p 31
###begin p 32
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 62 69 <span type="species:ncbi:9606">patient</span>
###xml 187 194 <span type="species:ncbi:9606">patient</span>
Figure 4 shows the result of the carotid ultrasonography in a patient with coronary heat disease and a young control subject. There was an apparent thickness of the carotid intima in the patient ultrasonography when compared with the control. Furthermore, there was a weak positive correlation between the CIT and the tHcy level, the correlation coefficient was 0.34.
###end p 32
###begin title 33
4. Discussion
###end title 33
###begin p 34
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
The principle findings of this study include the followings: first MTHFR gene mutation does not seem to be associated with the occurrence of coronary heart disease or the elevation of plasma tHcy in the studied patients. Plasma tHcy was significantly higher in elder patients with cardiovascular complications compared with the young control group. There was a significant positive correlation between plasma tHcy and age. Also, the high plasma tHcy was associated with the presence of mildly elevated serum urea and creatinine and poor glycemic control in the patients group. Moreover, the tHcy level correlated positively with the total serum cholesterol.
###end p 34
###begin p 35
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 908 910 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 350 358 <span type="species:ncbi:9606">patients</span>
###xml 667 670 <span type="species:ncbi:9606">Gp3</span>
In this study, plasma homocysteine in the young control group was higher than the reference ranges provided by other studies performed at different ethnic populations 8,14,24. This might represent an ethnic difference in plasma homocysteine and warrants a reference range study in the Egyptian population. The significantly higher plasma tHcy in the patients group compared with the young control group (Gp1) falls in line with the results of several previous studies which highlighted the causal relationship between the occurrence of the coronary heart diseases and the high plasma tHcy [14, 3 9, 40]. This finding might explain the higher degree of CIT in Gp2 and Gp3 compared to Gp1 (young healthy controls). It is hypothesized that the high tHcy level induces procoagulative effects that result in endothelial damage 41,42 that could precipitate the rupture of an established atherosclerotic plaque 25, 41,43.
###end p 35
###begin p 36
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 1363 1365 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 756 764 <span type="species:ncbi:9606">patients</span>
###xml 1146 1154 <span type="species:ncbi:9606">patients</span>
###xml 1239 1247 <span type="species:ncbi:9606">patients</span>
Plasma tHcy although affected by several factors that control the metabolism of homocysteine pathway [4 4, 45 ] the most important determinant of plasma homocysteine is the folate intake 46,47. Several previous reports illustrated the positive effect of folate intake on the reduction of plasma tHcy level and subsequent decrease in the incidence of cardiovascular diseases 46-49. In the present study there was no significant difference between the different groups included in this study regarding the folate level. Also, there was no correlation between the plasma tHcy and the folate level. This finding although surprising, it is in accordance with the result of Verhoef et al 50 who found no significant difference in the plasma folate level between patients with vascular diseases and controls50. The lack of significant difference regarding the folate level in the studied groups might be explained by the high level of fruits and green vegetables in the diet of the Egyptian population in general. However, the lack of correlation between the plasma tHcy and the folate could be explained by the presence of mild renal impairment in the patients group, as evidenced by the significantly higher level of urea and creatinine in the patients group compared with the other two groups. This mild renal impairment might cause a resistant hyperhomocysteinaemia 51despite the high folate intake as discussed below.
###end p 36
###begin p 37
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
As regard the relationship between tHcy and MTHFR mutation, in this study, we did not find a significant correlation between high tHcy levels and MTHFR genotypes in our patients. This finding is in keeping with a recent report 52 which found no association between the plasma tHcy and the MTHFR mutation, although in a meta-analysis, Klerk et al 53 found that the MTHFR 677TT genotype was associated with elevated tHcy level. However, most studies did not show an association between the MTHFR mutation and subsequent development of cardiovascular diseases 23,24,54. Our results are in keeping with the results of these studies.
###end p 37
###begin p 38
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
Since Frosste et al 17 suggested the C667T mutation as a possible reason for the occurrence of vascular complications; several groups have evaluated this hypothesis in cardiovascular patients from different ethnic groups 19, 21, 55.
###end p 38
###begin p 39
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
In the current study there was no significant difference between the patients group and the other two groups regarding the distribution of the TT genotype. These results are close to the results of previous studies that evaluated the TT genotype distribution in other ethnic populations 51,56,57.
###end p 39
###begin p 40
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
In the current study, when cases were stratified according to expression of the T allele and reanalyzed for the plasma tHcy, there was no significant increase in tHcy in the TT genotype individuals in the different groups. This finding supports more the lack of association between the presence of the T allele and the high tHcy levels in our patients. This could be explained by the presence of other factors that control tHcy 58,59 especially plasma folate and vitamin B1230. Furthermore the presence of other DNA mutations that could affect the homocysteine metabolism (e.g. A1298C mutation) 60. Another reason might be the relatively small number enrolled in our study.
###end p 40
###begin p 41
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 533 541 <span type="species:ncbi:9606">patients</span>
The current study showed a positive correlation between tHcy and age which is in keeping with previous results in different ethnic population 24, 60, 62, 63. This could be explained by the presence of other factors that raise plasma tHcy with age, especially the increased deterioration in other organ functions. The later was reflected in the present study by the higher incidence of impaired glycemic control and hypertension. Both have adverse effect on the renal function. Furthermore, previous reports found an elevated tHcy in patients with renal impairment and insulin resistance 64-67. Another possible reason may be the generalized slow down of some biological processes in the body with aging including methionine metabolism 61.
###end p 41
###begin p 42
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 107 114 <span type="species:ncbi:9606">patient</span>
###xml 652 655 <span type="species:ncbi:10116">rat</span>
The current study showed a significantly higher plasma glucose level both fasting and post-prandial in the patient group and Gp2 compared with the control. This impairment in the glycemic control most probably reflects a state of insulin resistance. Elevated homocysteine is associated with several cardiovascular disease risk factors including endothelial dysfunction and abnormalities of clotting functions, which are also common features of insulin resistance syndrome 65. Several studies have shown that the increase in insulin resistance was paralleled by a concomitant elevation of the plasma tHcy 66-68. Furthermore, it has been demonstrated in rat model that hyperinsulinaemia suppresses hepatocyte expression of cystathionine beta-synthase enzyme 69 with subsequent development of hyperhomocysteinaemia 69.
###end p 42
###begin p 43
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B75">75</xref>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B76">76</xref>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
###xml 770 778 <span type="species:ncbi:9606">patients</span>
###xml 1155 1163 <span type="species:ncbi:9606">patients</span>
This study also showed a positive correlation between the urea, and creatinine levels and plasma tHcy. The noticed impairment in the renal function is probably a complication of the cardiovascular disease itself (e.g. hypertension or heart failure) as patients with primary renal disease were not included in this study. This is in keeping with the results of several authors who reported an association between the impairment in renal functions and hyperhomocysteinaemia 70-72. Moreover, Jager et al 73 showed that hyperhomocysteinaemia is an independent determinant of the development of microalbuminuria among non-diabetic subjects and hypothesized that; tHcy may play a pathophysiological role in the development of microalbuminuria 73. The hyperhomocysteinaemia in patients with renal impairment was attributed to loss of renal homocysteine uptake and metabolism 74 which normally accounts for about 70% of daily homocysteine removal from the plasma 74, 75. Thus elimination of a substantial homocysteine metabolizing capacity of normal kidneys could account for the presence of this refractory high homocysteine despite the high folate level in the patients group 76
###end p 43
###begin p 44
###xml 86 93 <span type="species:ncbi:9606">patient</span>
In the current study, there was a significantly higher serum cholesterol level in the patient group when compared with the other two groups. Also, this high cholesterol correlated positively with the tHcy level. This high cholesterol might be attributed to increase in weight gain with age, lack of physical activity or improper life style with high intake of fatty foods. However, the association of high homocysteine found in the current study and the cholesterol level could be explained by causal relationship between plasma tHcy and cholesterol.
###end p 44
###begin p 45
###xml 11 13 11 13 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
Li H et al 77 demonstrated that high plasma tHcy has a positive effect on the hydroxyl methyl glutaryl -CoA synthase enzyme ( the rate limiting enzyme in cholesterol biosynthesis) and hence hypercholesterolaemia. Furthermore, they suggested that elevated homocysteine increases the cholesterol accumulation in the endothelial cells and suggested the use of statins in patients with elevated homocysteine even without hypercholesterolaemia.
###end p 45
###begin p 46
###xml 229 237 <span type="species:ncbi:9606">patients</span>
In conclusion this study has shown a positive association between elevated plasma tHcy and age. There was no association between the MTHFR mutation and either the presence of coronary heart disease or the high plasma tHcy in our patients. Furthermore, there was a positive correlation between the plasma tHcy and impairment of both renal functions and glycemic control.
###end p 46
###begin p 47
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
However, the relationship between plasma tHcy and other mutations in the MTHFR gene such as the A1298C and the degree of insulin resistance in the studied groups remains to be addressed. Furthermore, a recent report 67 stressed on the crucial role played by cytokines in the evolution of insulin resistance. Could hyperhomocysateineamia be a result of derangement of certain cytokine production?
###end p 47
###begin title 48
ABBREVIATIONS
###end title 48
###begin p 49
 total homocysteine
###end p 49
###begin p 50
 methylenetetrahydrofolate reductase
###end p 50
###begin p 51
 Group
###end p 51
###begin p 52
 Carotid intimal thickness
###end p 52
###begin article-title 53
Homocysteine metabolism
###end article-title 53
###begin article-title 54
The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine
###end article-title 54
###begin article-title 55
###xml 60 63 <span type="species:ncbi:9606">men</span>
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
###end article-title 55
###begin article-title 56
The effects of vitamins B12, B6, and folate on blood homocysteine levels
###end article-title 56
###begin article-title 57
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
In the cystathionine beta-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific
###end article-title 57
###begin article-title 58
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human homocysteine catabolism: three major pathways and their relevance to development of arterial occlusive disease
###end article-title 58
###begin article-title 59
###xml 46 50 <span type="species:ncbi:10116">rats</span>
Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism
###end article-title 59
###begin article-title 60
Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate
###end article-title 60
###begin article-title 61
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
###end article-title 61
###begin article-title 62
A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk
###end article-title 62
###begin article-title 63
###xml 19 25 <span type="species:ncbi:9606">people</span>
Should all elderly people receive folate supplements?
###end article-title 63
###begin article-title 64
Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting
###end article-title 64
###begin article-title 65
Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death
###end article-title 65
###begin article-title 66
Plasma Homocysteine, Hypertension Incidence, and Blood Pressure Tracking: The Framingham Heart Study
###end article-title 66
###begin article-title 67
Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography
###end article-title 67
###begin article-title 68
Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease
###end article-title 68
###begin article-title 69
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
###end article-title 69
###begin article-title 70
Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects
###end article-title 70
###begin article-title 71
The frequency of the C677T substitution in the methylenetetrahydrofolate reductase gene in Manitoba
###end article-title 71
###begin article-title 72
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease
###end article-title 72
###begin article-title 73
###xml 93 98 <span type="species:ncbi:9606">women</span>
Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups
###end article-title 73
###begin article-title 74
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
###end article-title 74
###begin article-title 75
A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction
###end article-title 75
###begin article-title 76
Homozygosity for the C 677 ->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden
###end article-title 76
###begin article-title 77
Methylenetetrahydrofolate reductase (MTHFR) mutation, homocysteine, and coronary artery disease
###end article-title 77
###begin article-title 78
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
###end article-title 78
###begin article-title 79
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
###end article-title 79
###begin article-title 80
Hyperhomocysteinemia and the response to vitamin supplementation
###end article-title 80
###begin article-title 81
Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure
###end article-title 81
###begin article-title 82
The effect of folic acid fortification on plasma folate and total homocysteine concentrations
###end article-title 82
###begin article-title 83
Clinical implications of carotid artery remodeling in acute coronary syndrome: ultrasonographic assessment of positive remodeling
###end article-title 83
###begin article-title 84
###xml 104 109 <span type="species:ncbi:9606">women</span>
Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women
###end article-title 84
###begin article-title 85
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension
###end article-title 85
###begin article-title 86
###xml 137 145 <span type="species:ncbi:9606">patients</span>
Plasma homocysteine, methylenetetrahydrofolate reductase gene polymorphism and carotid intima-media thickness in Italian type 2 diabetic patients
###end article-title 86
###begin article-title 87
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an indepedent risk determinant of carotid wall thickening: The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
###end article-title 87
###begin article-title 88
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease
###end article-title 88
###begin article-title 89
Hardy-Weinberg equilibrium and the estimation of gene frequencies
###end article-title 89
###begin article-title 90
Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study
###end article-title 90
###begin article-title 91
Homocysteine and cardiovascular disease: cause or effect?
###end article-title 91
###begin article-title 92
A theory for the mechanism of homocysteine-induced vascular pathogenesis
###end article-title 92
###begin article-title 93
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease
###end article-title 93
###begin article-title 94
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study
###end article-title 94
###begin article-title 95
###xml 131 139 <span type="species:ncbi:9606">Patients</span>
Consumption of Whole Grain and Legume Powder Reduces Insulin Demand, Lipid Peroxidation, and Plasma Homocysteine Concentrations in Patients With Coronary Artery Disease: Randomized Controlled Clinical Trial
###end article-title 95
###begin article-title 96
Homocysteine and coronary risk
###end article-title 96
###begin article-title 97
Relationship between plasma homocysteine and vitamin status in the Framingham study population
###end article-title 97
###begin article-title 98
Folic acid fortification of food
###end article-title 98
###begin article-title 99
Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour
###end article-title 99
###begin article-title 100
B vitamins and plasma homocysteine concentrations in an urban and rural area of Costa Rica
###end article-title 100
###begin article-title 101
Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis
###end article-title 101
###begin article-title 102
Renal metabolism of homocysteine in vivo
###end article-title 102
###begin article-title 103
###xml 165 173 <span type="species:ncbi:9606">patients</span>
Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients
###end article-title 103
###begin article-title 104
MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis
###end article-title 104
###begin article-title 105
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study
###end article-title 105
###begin article-title 106
Prevalence of the C677T substitution of the methylenetetrahydrofolate reductase (MTHFR) gene in Wisconsin
###end article-title 106
###begin article-title 107
The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease
###end article-title 107
###begin article-title 108
Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis
###end article-title 108
###begin article-title 109
Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
###end article-title 109
###begin article-title 110
Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
###end article-title 110
###begin article-title 111
###xml 28 33 <span type="species:ncbi:9606">human</span>
A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations
###end article-title 111
###begin article-title 112
Can homocysteine be related to physical functioning?
###end article-title 112
###begin article-title 113
Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians
###end article-title 113
###begin article-title 114
Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study Cohort
###end article-title 114
###begin article-title 115
Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects
###end article-title 115
###begin article-title 116
Plasma total homocysteine levels in subjects with hyperinsulinemia
###end article-title 116
###begin article-title 117
Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects
###end article-title 117
###begin article-title 118
Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease
###end article-title 118
###begin article-title 119
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study
###end article-title 119
###begin article-title 120
Insulin secretion as a potential determinant of homocysteine levels
###end article-title 120
###begin article-title 121
From microalbuminuria to hyperhomocysteinemia
###end article-title 121
###begin article-title 122
Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine
###end article-title 122
###begin article-title 123
Renal disease, homocysteine, and cardiovascular complications
###end article-title 123
###begin article-title 124
Serum Homocysteine Levels Are Associated With the Development of Microalbuminuria: The Hoorn Study
###end article-title 124
###begin article-title 125
Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes
###end article-title 125
###begin article-title 126
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure
###end article-title 126
###begin article-title 127
###xml 110 118 <span type="species:ncbi:9606">patients</span>
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study
###end article-title 127
###begin article-title 128
Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial Cells: A Mechanism for Development of Atherosclerosis?
###end article-title 128
###begin p 129
###xml 0 17 0 17 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mohamed EL-SAMMAK</bold>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
Mohamed EL-SAMMAK obtained MSc (1998) and Ph.D (2001) in Clinical Laboratory Sciences from Nottingham University, UK, and MRCPath (2003) from Royal College UK. He currently works as a lecturer & honorary Consultant in Clinical Pathology at Alexandria University, Egypt. He is involved in several research projects such as the evaluation of methylenetetrahdrofolate reductase gene mutation in Egyptian patients with coronary heart disease; evaluation of the clinical utility of procalcitonin in tonsilopharingitis of various etiologies; ACE gene polymorphism in patients with pre-eclampsia.
###end p 129
###begin p 130
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mona Kandil</bold>
Mona Kandil (MBCHB, MSc, PhD,MD) is a professor and head of Clinical Pathology department in Alexandria University, and her main research interest is Molecular Chemical Pathology.
###end p 130
###begin p 131
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Safaa El-Hifni</bold>
Safaa El-Hifni (MBCHB, MSc, PhD, MD) is an emirates professor in Clinical Pathology at Alexandria University where she has been head of the department in Alexandria Medical Research Institute Teaching hospital till 2001. Her main research interest is analytical Chemical Pathology especially Chromatography and mass spectroscopy.
###end p 131
###begin title 132
Figures and Tables
###end title 132
###begin p 133
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinf</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hinf</italic>
Different MTHFR genotypes.3% agarose gel electrophoresis showing the different genotypes of the MTHFR mutation. DNA samples were amplified using PCR and digested with Hinf1 restriction enzyme. The presence of C to T mutation creates a Hinf1 restriction site. Lane 1: 100 base pairs (Bp) ladder marker. Lane 2: Negative control (no DNA was added.) Lane 3, 4, 5: Wild type CC genotype. Only one band could be seen at approximately the 198 Bp. Lane 6: CT heterozygous genotype. Two DNA fragments could be seen. The first at the 198 Bp, while the second at the 175 Bp. Lane 7: TT homozygous genotype. Only one band is seen at the approximately the 175 Bp.
###end p 133
###begin p 134
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 238 241 <span type="species:ncbi:9606">Gp3</span>
Plasma homocysteine in the studied groups. Bar Chart illustrating the plasma homocysteine in the young control group (Gp1, age range 35-50 years) and the Gp2 (elderly control subjects aged between 50 and 75 years) and the patients group (Gp3, age range: 50-75 years). The number of subjects included was 50 in each group. * Significant difference versus (Gp1). P<0.05.
###end p 134
###begin p 135
The effect of the T allele on the plasma homocysteine in the different studied groups. Bar chart illustrating the effect of the T allele on the level of homocysteine in the different groups. Cases were stratified according to the genotype into CC (wild type) and TT (mutant homozygous). MTHFR: Methylene tetrahydrofolate reductase. * Significant difference versus the TT genotype. P<0.05.
###end p 135
###begin p 136
###xml 66 73 <span type="species:ncbi:9606">patient</span>
###xml 506 513 <span type="species:ncbi:9606">patient</span>
Ultrasonography for the carotid artery in a control subject and a patient with coronary heart disease. Carotid ultrasonography for measurement of the carotid artery intimal thickness (CIT) was done using the ultrasonic machine equipped with high frequency linear array transducer. The examination was done for the right and left common carotid arteries and the mean values of the two sites were used in the analysis. There is an apparent increase in the degree of carotid intimal thickness in the examined patient (0.9mm) compared with 0.6 mm in the control subject.
###end p 136
###begin p 137
Some clinical and biochemical data of the different groups included in the study.
###end p 137
###begin p 138
Gp: group, SBP: systolic blood pressure, DBP: diastolic blood pressure, CIT: Carotid intimal thickness in millimeters, FBG, Fasting blood glucose, PPBG: Post-prandial blood glucose, TC: Total cholesterol, TG: triglycerides, HDL-C. High density lipoprotein cholesterol, tHcy: Total homocysteine.
###end p 138
###begin p 139
*: Significant difference versus the young control group (Gp1). P<.005 was considered significant.
###end p 139
###begin p 140
Frequency of the MTHFR genotypes and the result of the Chi square testing in the different studied groups. Showing the frequency and the results of the cross tabulation of the T allele and the different genotypes in the studied groups. The total number of cases was 50 in each group. There was no significant difference regarding the distribution of the CC, CT, TT genotypes in the three studied groups (P>0.05). Chi square test (Exact Fisher test) was used.
###end p 140

